Favourable pregnancy outcome following gliclazide use throughout pregnancy in diabetic female Sprague-Dawley rats
No Thumbnail Available
Date
2018
Journal Title
Journal ISSN
Volume Title
Publisher
Lagos State University College of Medicine
Abstract
Objectives: The incidence of diabetes mellitus (DM) is associated with complications with reproduction.
The effect of gliclazide on pregnancy hormones and fetal outcomes in diabetic female rats was determined in
this study.
Methods: There were four experimental groups (control, diabetic control, gliclazide-treated and diabetictreated)
of 20 rats each. Studies were carried out on days 7, 14, 19 and at term, to ascertain implantation,
gestation, fetal outcome and measurement of some plasma hormone levels. Values represent mean ± SD and
were analyzed by two-tailed ANOVA followed by a Post-hoc test. Differences were considered significant at
p<0.05.
Results: There were increases inplasma estradiol in the gliclazide-treated non-diabetic [day 14 (55.80±1.0;
p=0.01), day 19 (55.80±3.1;p=0.02)] and diabetic [day 14 (25.42±1.7); p=0.03] groups, and also in plasma
progesterone in the treated diabetic group [day 14 (35.12±6.2) p=0.02] only. Plasma corticosterone and
plasma CRP decreased in the gliclazide-treated [corticosterone day 14 (356.30±24.1) p=0.01; day 19
(308.30±17.6) p=0.01]; [CRP day 14 (0.13±0.05) p=0.01] and the diabetic-treated [corticosterone day 14
(400.50±21.5) p=0.01, day 19 (424.10±22.4) p=0.01; [CRP day 14 (0.14±0.13) p=0.01] groups. There were
no significant changes in the plasma levels of β-hCG and no abnormalities were observed in litters from all
groups.
Conclusion: Gliclazide improved some reproductive complications in the diabetic state and in the nondiabetic
state. Consideration should be given to its use in managing reproductive complications associated
with DM.
Description
Keywords
pregnancy, fetal outcome, alloxan, diabetes mellitus